Tradition and innovation go hand in hand: Curcumin HEVERT OPTISOLV® is now available in pharmacies
Hevert-Arzneimittel and startup EVANIUM combine expertise in herbal medicine and modern technology to launch Curcumin HEVERT OPTISOLV®. Using OPTISOLV® Technology, this natural turmeric supplement offers enhanced solubility and bioavailability. Now available in pharmacies.
EVANIUM is featured in the EIT program
Regensburg – We are delighted that EVANIUM has been featured in the renowned EIT (European Institute of Innovation and Technology) program. This recognition highlights our innovative strength and our commitment to forward-looking technologies. Since our founding in 2019 at the BioPark Regensburg innovation center, we have steadily grown and developed solutions that deliver real added […]
EVANIUM secures successful seed funding – Report in the Mittelbayerische Zeitung
Regensburg, November 30, 2023 – The Mittelbayerische Zeitung reported on our successful seed funding round! Since our founding in 2019 at the BioPark Regensburg innovation center, we have experienced significant growth – our team now comprises ten dedicated employees. The funding round was a crucial milestone for our continued growth. “That was super important,” says […]
GründerLIFT #052 – Is the alignment correct?
When Evanium’s founding team first met at Startupfactory 2017, part of the Digital Start-up Initiative Upper Palatinate, they had only a spark of an idea and a shared curiosity for biotech innovation. Since then, the path has been anything but linear. In the latest GründerLIFT! podcast episode, co-founder and CEO Felix Rolka takes listeners behind […]
Interview with EVANIUM Co-Founder David Ofner
David Ofner, co-founder of EVANIUM, oversees research on improving the water solubility and bioavailability of plant-based substances, coordinates university collaborations, and leads in vitro studies on neuroprotective flavonoid complexes. Inspired by early exposure to traditional Chinese medicine and a fascination with maximizing the effectiveness of active ingredients, he founded Evanium to unlock the potential of poorly soluble substances. The company aims to expand its platform technology for plant extracts, develop proprietary active ingredients, and provide effective plant-based solutions for the health and consumer care sectors.
FAH member EVANIUM Healthcare GmbH introduces itself
EVANIUM develops innovative, IP-protected plant-based health ingredients, focusing on bioactive flavonoids for the food, consumer care, and pharmaceutical sectors. Many flavonoids have health benefits but face challenges like poor solubility and stability. Using its OPTISOLV® Technology, EVANIUM improves these properties, creating highly soluble, stable, and bioavailable plant extracts. The company also researches novel applications, conducts in silico and in vitro testing, and offers contract development, joint collaborations, and branded raw materials for industry partners.